What Happens at a Lip Filler Consultation — and Why the Phone Call Before It Decides Whether You Get One

A lip filler consultation is a medical appointment that most people book like a haircut. That mismatch is where premium injectable practices lose revenue — not in the treatment room, but in the ninety seconds before anyone reaches one.

The volume is not in question. The American Society of Plastic Surgeons recorded 5,331,426 hyaluronic acid filler procedures in 2024, and 1,449,565 lip augmentations with injectable materials, both up one percent year over year. ASPS added a separate line that year for HA fillers used specifically for lip augmentation: 1,589,502 procedures. The society's own footnote warns that the two lip rows must not be combined, because of overlap and double-counting risk. Either way, lip augmentation has stayed in the top five minimally invasive procedures every year ASPS has tracked it.

A real lip filler consultation covers five things

Prospective patients search this phrase because they do not know what they are walking into. The honest answer is that a competent consultation is a clinical assessment, not a menu selection, and it covers the following.

• Product selection against an approved indication. Only seven hyaluronic acid fillers carry a US Food and Drug Administration lip augmentation indication: Juvéderm Ultra XC and Juvéderm Volbella XC from Allergan Aesthetics, Restylane-L, Restylane Silk and Restylane Kysse from Galderma, Revanesse Lips+ from Prollenium, and RHA 3 from Teoxane and Revance. Products a patient may have heard of — Juvéderm Vollure XC, RHA 2, RHA Redensity — are approved for facial wrinkles, folds or perioral lines, not lip augmentation. Using them in lips is off-label, which is lawful for a physician but is a disclosure conversation, not a silence.

• Age and candidacy. FDA labeling is specific and not uniform: Juvéderm and Restylane lip indications read "over the age of 21," while Revanesse Lips+ and RHA 3 read "22 years of age or older."

• Vascular risk and reversal. The FDA's own consumer guidance states that "the most serious risk associated with dermal fillers is accidental injection into a blood vessel." A 2024 review in Aesthetic Surgery Journal by Doyon, Beleznay and colleagues identified 365 reported cases of partial or complete vision loss following filler injection, with hyaluronic acid implicated in 79.6 percent and no recovery in 68.2 percent of cases with outcome data. These are case counts, not incidence rates — no denominator exists, and any practice quoting a per-injection risk percentage is quoting something nobody has measured.

• Anatomy the injector is working around. An ultrasound study by Cotofana and colleagues found the superior and inferior labial arteries most frequently in the submucosal plane, at mean depths of 5.6 and 5.2 millimeters, and concluded in favor of a superficial injection plane for lip volumization.

• Delayed reactions. Unlike blindness, these do have published rates. A 2022 review in Dermatologic Surgery covering 13,136 subjects across 28 studies put delayed reactions to hyaluronic acid fillers at 0 to 3.83 percent, mean 1.13 percent, varying by filler type.

A consultation that skips all five and goes straight to syringe count is not a consultation. It is an upsell with a chair.

Who is legally permitted to inject varies by state, and the gap is wider than patients assume

The FDA regulates the device. Who may inject it is entirely a matter of state law, and the picture is uneven. The American Medical Association reported in April 2026, citing a study in Dermatologic Surgery, that 36 states have no regulations or laws in place for medical spas and 44 states lack patient-protection regulations specific to them. The same reporting found that 70 percent of medical spas have no affiliation with a physician practice.

A 2024 study by the American Society for Dermatologic Surgery Association, covering 63 medical spas in Las Vegas, Nevada, found that 73 percent of injectable treatments were performed by non-physicians, dermal filler injections among the most common at 78.1 percent, with a supervising physician present in only 38.1 percent of cases. One finding in that study belongs on a whiteboard in every practice: 39.7 percent had no after-hours phone number.

The American Med Spa Association calls the good faith exam "the medical spa widow-maker," and its published position is that the exam must be performed by a physician, physician assistant or advanced practice nurse, and that registered nurses "cannot independently administer the exam or generate orders for treatment based on the exam." State rules differ, and a practice should confirm its own against its state board rather than against an internet table.

The consultation is the product, which is why the phone call is the bottleneck

Here is the operational number that reframes the whole category. Zenoti's 2026 Beauty and Wellness Benchmark Report, drawn from calendar-year 2025 transaction data across North American businesses on its platform, puts the median medspa online booking rate at 13 percent — the lowest of any vertical in the dataset. The report attributes this directly to "the consultation-driven nature of the business."

Read that the other way around. Roughly 87 percent of medspa bookings do not happen on the website. They happen through a human, and overwhelmingly through a phone. The website is a brochure; the phone is the checkout.

That same report records median staff utilization of 38 percent against 80 percent at the ninetieth percentile — the widest gap of any vertical it measures — and new guest visits down 11 percent year over year. A practice can have unbooked capacity and unanswered demand at the same moment, and most do.

Callers decide on injector credentials, product, cost and pain before they book

The American Society for Dermatologic Surgery's 2025 consumer survey, covering more than 3,500 consumers, found that cost is a leading factor in provider selection, that board certification, physician referral and level of licensure rank highest in driving consumer influence, and that 94 percent of respondents said rating and review sites affect which provider they select. Cost at 24 percent and pain at 14 percent were the leading reasons for hesitation.

Every one of those is a question a caller wants answered before committing to an appointment: who will be injecting, what are their credentials, which product, what does it cost, does it hurt, and what happens if something goes wrong. It is the same credential-and-competence screen we mapped in what affluent callers actually want, arriving one question earlier than most practices expect. ASPS puts the national average fee for lip augmentation with dermal fillers at $743. RealSelf's patient-reported average across 265 reviews is $660, with a range from $340 to $1,500.

None of those questions requires a physician to answer at first contact. All of them require someone to pick up. This is the same failure we mapped in the "we'll call you back" pattern and in the after-hours pickup data. It is Pillar 1, the Zero-Miss Intake Protocol, in its most literal form.

Speed matters, and the honest version of the evidence is narrower than the marketing version

The research everyone cites here is Oldroyd, McElheran and Elkington in Harvard Business Review, March 2011. Their audit of 2,241 US companies found an average response time of 42 hours among those that responded within 30 days, with 23 percent never responding at all. Their second study, across 1.25 million leads, found firms contacting a prospect within an hour were "nearly seven times as likely to qualify the lead" as those trying an hour later, and more than 60 times as likely as those waiting a day.

Two corrections worth making, because most aesthetics marketing gets them wrong. The HBR finding is hour-based, not the widely quoted five minutes, and the outcome measured is qualifying the lead, not booking or closing it. The "five-minute rule" traces to the separate Lead Response Management study, conducted on 2007-era mortgage and insurance leads rather than healthcare, and no longer hosted at its original domain. The direction of the finding is well supported. The precision claimed for it usually is not.

At published averages, 24 missed first contacts a month puts the annual gap in the low six figures

Take a single-location injectable practice at the AmSpa 2024 report's averages: 245 patient visits per month, $527 average spend per visit, $1,398,833 in annual revenue, and 73 percent repeat patients. Assume 120 new-patient calls a month and a 20 percent missed-call rate — substitute your own, because it is the only input here you can measure directly. That is 24 first contacts a month that reach no one.

If a quarter of those would have booked a consultation, and the practice's repeat rate held, the annual gap sits in the low six figures against a first-visit value alone — before any retreatment cycle. Illustrative model based on published AmSpa and Zenoti averages — not a client result or guarantee. Substitute your own call volume and your own answer rate, and the shape of the answer does not change.

Retreatment is where the arithmetic compounds

Filler is not a one-time transaction, and FDA-labeled duration data is more sober than the marketing. Juvéderm Ultra XC's pivotal data showed 56.4 percent of subjects still responding at 12 months. Restylane Kysse showed 60 percent investigator-rated improvement in lip fullness at 12 months. RHA 3's device summary reports roughly 48 percent at one year.

So a lip filler patient is a recurring patient on a roughly annual cycle, and AmSpa's 2024 report puts repeat patients at 73 percent of medical spa visits, up from 65 percent in the prior survey. A missed first call does not cost one appointment. It costs the cycle. The Zenoti data makes the same point from the other end: where guests were rebooked once, 37 percent of those appointments were cancelled, but among guests rebooked two or more times, cancellation fell to 4 percent. Continuity is the asset.

Frequently asked questions

What happens at a lip filler consultation? A qualified injector assesses lip anatomy and facial proportion, reviews medical history and prior filler, selects a product with an approved lip indication, explains vascular risk and hyaluronidase reversal, discusses expected duration and cost, and — in most states — completes a good faith examination before any product is ordered.

How much does a lip filler consultation cost? Practices vary; many apply the consultation fee to treatment. ASPS puts the national average fee for lip augmentation with dermal fillers at $743, and RealSelf's patient-reported average at $660 across 265 reviews.

Which fillers are FDA-approved for lips? Seven: Juvéderm Ultra XC, Juvéderm Volbella XC, Restylane-L, Restylane Silk, Restylane Kysse, Revanesse Lips+ and RHA 3. Others are approved for different areas and would be used off-label in lips.

Can a nurse inject lip filler? It depends on the state. Scope of practice, supervision and delegation rules are set by state medical and nursing boards, and 36 states have no medical spa regulations at all according to April 2026 AMA reporting. Ask who will inject, what their licence is, and who supervises.

How long does lip filler last? FDA-labeled data shows roughly half to sixty percent of subjects still responding at twelve months, depending on product. Ask whether a duration claim comes from a lip trial or a nasolabial fold trial. Galderma's "up to 18 months" for Restylane applies to facial wrinkles and folds, and Revance's RHA "up to 15 months" is footnoted to a nasolabial fold trial.

You know your conversion rate; you do not know how many callers reached no one

You already know your consultation-to-treatment rate. You already know your average ticket. You almost certainly do not know how many people called your practice last month and reached no one — and neither does the practice down the street, which is the point.

Answering the phone is not a technology problem, and none of this argues for removing a human from the front desk. It argues the opposite: an injectable practice's coordinator is worth far more standing in the treatment room translating a consultation than sitting at a desk absorbing the fourth "how much is lip filler" call of the morning. The auxiliary layer catches the calls nobody is free to take, answers the five questions that decide the booking, and hands the coordinator a consultation already on the calendar.

References

• American Society of Plastic Surgeons, 2024 Plastic Surgery Statistics Report, released 25 June 2025; ASPS national average fee page, retrieved July 2026.

• US Food and Drug Administration, PMA database records for P050047, P110033, P040024, P140029, P160042, P170002; "Dermal Fillers (Soft Tissue Fillers)" and "Dermal Filler Do's and Don'ts," content current 2023.

• Doyon, Beleznay et al., Aesthetic Surgery Journal 2024;44(10):1091-1104.

• Cotofana et al., Aesthetic Surgery Journal 2020;40(12):1327-1335.

• Kokoska et al., Dermatologic Surgery 2022;48(7):752-757; Humphrey et al., Journal of the American Academy of Dermatology 2020;83(1):86-95.

• American Medical Association, "36 states lack regulatory oversight of med spas," 6 April 2026, reporting a Dermatologic Surgery study, August 2025.

• American Society for Dermatologic Surgery Association, "Supervision Unveiled: Navigating the Supervision Landscape in Medical Spas," reported by Healio, 10 January 2025.

• American Med Spa Association, "Good Faith Exams: The Medical Spa Widow-maker," 30 October 2020.

• American Society for Dermatologic Surgery, 2025 Consumer Survey on Cosmetic Dermatologic Procedures, 28 July 2025.

• Zenoti, "The 2026 Beauty and Wellness Benchmark Report: Medspa edition," 29 April 2026 (calendar-year 2025 platform data).

• American Med Spa Association, 2024 Medical Spa State of the Industry Report, released 10 June 2024 (survey fielded September 2023 to March 2024).

• Oldroyd, McElheran and Elkington, "The Short Life of Online Sales Leads," Harvard Business Review, March 2011.

• RealSelf lip filler cost page, updated 27 September 2024.

Next Step

If your premium practice runs more than 100 inbound consult inquiries a month and has no structured measurement of how many never reach a scheduled consultation, your pipeline is leaking revenue. We quantify this for your practice in a 30-minute Intake Leak Audit.

• Request an Intake Leak Audit: expand@thethinkingrobot.com

• Audit Real-Time Conversational Velocity: Talk to Rosey, our AI receptionist, at +1 (720) 776-1664.